FHIR
© HL7.org |
Server Home
|
XIG Home
|
Server Source
|
FHIR
FHIR IG Statistics: FHIR Resources
Version:
All
|
R2
|
R2B
|
R3
|
R4
|
R4B
|
R5
|
R6
Authority:
All
|
hl7
|
ihe
|
national
Realm:
All
|
BNW
|
au
|
be
|
br
|
ca
|
ch
|
cl
|
cr
|
cz
|
de
|
dk
|
ee
|
eu
|
fi
|
fr
|
il
|
in
|
it
|
jp
|
nl
|
no
|
nz
|
pt
|
se
|
sl
|
stt
|
tw
|
uk
|
us
|
uv
|
vn
View:
All
|
Resource Profiles
|
Datatype Profiles
|
Extensions
|
Logical Models
|
CodeSystems
|
ValueSets
|
ConceptMaps
Resources - All Kinds, Realm US, Authority Hl7
16,284 resources
Type:
ActivityDefinition
ActorDefinition
CapabilityStatement
CodeSystem
ConceptMap
ExampleScenario
GraphDefinition
ImplementationGuide
Measure
MessageDefinition
NamingSystem
OperationDefinition
PlanDefinition
Questionnaire
Requirements
SearchParameter
StructureDefinition
StructureMap
TerminologyCapabilities
TestScript
ValueSet
Text:
By Version
R2
: 52
R2B
: 0
R3
: 523
R4
: 15,269
R4B
: 0
R5
: 440
R6
: 0
Start
Prev
Rows 10800 - 11000
Next
Package
Version
Identity
Name/Title
Status
FMM
WG
Date
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.101.12.1087
Outpatient Encounter
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.101.12.1088
Frailty Encounter
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.101.12.1090
Palliative Care Encounter
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1010
Multiple Myeloma
active
2021-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1011
Multiple Myeloma
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1012
Premature Menopause
active
2021-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1013
Premature Menopause
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1014
Multiple Myeloma
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1015
Premature Menopause
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1019
Amenorrhea
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1031
Acute Pharyngitis
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1033
Acute Pharyngitis
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1034
Acute Tonsillitis
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1036
Acute Tonsillitis
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1058
Upper Respiratory Infection
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1059
Upper Respiratory Infection
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1066
Comorbid Conditions for Respiratory Conditions
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.11.1067
Comorbid Conditions for Respiratory Conditions
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.12.1011
Acute Pharyngitis
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.12.1012
Acute Tonsillitis
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.12.1017
Competing Conditions for Respiratory Conditions
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.12.1022
Upper Respiratory Infection
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.102.12.1025
Comorbid Conditions for Respiratory Conditions
active
2022-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1021
Amenorrhea
active
2022-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1022
Amenorrhea
active
2023-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1025
Bilateral Oophorectomy
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1026
Unilateral Oophorectomy Left
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1028
Unilateral Oophorectomy Left
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1029
Unilateral Oophorectomy Left
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.103.12.1001
Diabetes
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.103.12.1020
Type 1 Diabetes
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1030
Unilateral Oophorectomy Right
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1031
Unilateral Oophorectomy Right
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1032
Unilateral Oophorectomy Right
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1034
Unilateral Oophorectomy, Unspecified Laterality
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1035
Unilateral Oophorectomy, Unspecified Laterality
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1036
Eating Disorders
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1038
Eating Disorders
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1039
Eating Disorders
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.104.11.1029
Essential Hypertension
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.104.11.1031
Essential Hypertension
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.104.12.1011
Essential Hypertension
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1040
Major Transplant
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1042
Major Transplant
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1043
Potentially Harmful Antihistamines for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1046
Evidence of Bilateral Oophorectomy
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1048
Evidence of Bilateral Oophorectomy
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1049
Potentially Harmful Antiparkinsonian Agents for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1010
Mental Health Diagnoses
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1012
Mental Health Diagnoses
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1017
Major Depression
active
2023-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1019
Major Depression
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1060
Major Depression In Remission
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1062
Major Depression In Remission
active
2025-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1161
Schizophrenia or Psychotic Disorder
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1162
Schizophrenia or Psychotic Disorder
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1163
Schizophrenia or Psychotic Disorder
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1206
Mental Behavioral and Neurodevelopmental Disorders
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1207
Mental Behavioral and Neurodevelopmental Disorders
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1210
Schizophrenia
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1211
Schizophrenia
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1212
Seizure Disorder
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1213
Seizure Disorder
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1214
REM
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1215
REM
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1216
Benzodiazepine Withdrawal
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1217
Benzodiazepine Withdrawal
active
2025-04
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1218
Alcohol Withdrawal
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1219
Alcohol Withdrawal
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1220
General Anxiety
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.11.1221
General Anxiety
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1004
Mental Health Diagnoses
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1007
Major Depression
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1104
Schizophrenia or Psychotic Disorder
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1203
Mental Behavioral and Neurodevelopmental Disorders
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1205
Schizophrenia
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1206
Seizure Disorder
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1207
REM Sleep Behavior Disorder
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1208
Benzodiazepine Withdrawal
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1209
Alcohol Withdrawal
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.105.12.1210
Generalized Anxiety Disorder
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1050
Potentially Harmful Gastrointestinal Antispasmodics for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1051
Dipyridamole Medications
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1053
Nifedipine Medications
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1054
Potentially Harmful Antidepressants for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1055
Potentially Harmful Barbiturates for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1057
Meprobamate Medications
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1058
Potentially Harmful Estrogens for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1059
Potentially Harmful Sulfonylureas for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.11.1001
Substance Use Disorder
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.11.1003
Substance Use Disorder
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.11.1012
Substance Use Disorder Treatment
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.11.1036
Substance Use Disorder Treatment
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.12.1001
Substance Use Disorder
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.106.12.1005
Substance Use Disorder Treatment
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1060
Desiccated Thyroid Medications
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1062
Potentially Harmful Skeletal Muscle Relaxants for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1063
Potentially Harmful Pain Medications for Older Adults
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1065
Digoxin Medications
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1066
Digoxin Medications
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1067
Doxepin Medications
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.1068
Doxepin Medications
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1001
Malignant Neoplasm of Colon
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1003
Malignant Neoplasm of Colon
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1025
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1027
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1044
Pap Test
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1047
Mammography
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1051
Colonoscopy
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1052
Colonoscopy
active
2017-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1053
Colonoscopy
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.11.1145
sDNA FIT Test
active
2017-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1001
Malignant Neoplasm of Colon
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1009
Malignant Neoplasm of Lymphatic and Hematopoietic Tissue
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1017
Pap Test
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1018
Mammography
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1020
Colonoscopy
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1038
CT Colonography
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.108.12.1039
sDNA FIT Test
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1024
Kidney Transplant
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1025
Kidney Transplant
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1026
Dialysis Services
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1027
Dialysis Services
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1028
Dialysis Services
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1029
ESRD Monthly Outpatient Services
active
2017-08
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1052
Kidney Transplant
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1060
Kidney Transplant Recipient
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.11.1067
Kidney Transplant
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.12.1012
Kidney Transplant
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.12.1013
Dialysis Services
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.12.1014
ESRD Monthly Outpatient Services
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.109.12.1029
Kidney Transplant Recipient
active
2024-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065
DTaP Vaccine Administered
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1066
DTaP Vaccine Administered
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1068
Hepatitis A
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1070
Hepatitis A
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1078
Measles
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1080
Measles
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1085
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1086
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1087
Mumps
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1089
Mumps
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1098
Rubella
active
2021-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.110
Rubella
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1104
Varicella Zoster
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1105
Varicella Zoster
active
2025-01
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1106
Varicella Zoster Vaccine (VZV) Administered
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1107
Varicella Zoster Vaccine (VZV) Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1109
Hepatitis A Vaccine Administered
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1110
Hepatitis A Vaccine Administered
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1111
Hepatitis B Vaccine Administered
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1112
Hepatitis B Vaccine Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115
Child Influenza Vaccine Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116
Child Influenza Vaccine Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1117
Inactivated Polio Vaccine (IPV) Administered
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1118
Inactivated Polio Vaccine (IPV) Administered
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1119
Pneumococcal Conjugate Vaccine Administered
active
2023-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1120
Rotavirus Vaccine (3 dose schedule) Administered
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1121
Rotavirus Vaccine (2 dose schedule) Administered
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1123
Genital Herpes
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1124
Genital Herpes
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1128
Lab Tests for Sexually Transmitted Infections
active
2022-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1129
Chlamydia Screening
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1133
Pneumococcal Conjugate Vaccine Administered
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1135
HPV Test
active
2024-11
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1148
Rotavirus Vaccine (2 Dose Schedule) Administered
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1149
Rotavirus Vaccine (3 Dose Schedule) Administered
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1150
Advanced Illness
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1151
Advanced Illness
active
2025-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1152
HiB Vaccine (3 dose schedule)
active
2021-12
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153
HiB Vaccine (3 dose schedule) Administered
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154
HiB Vaccine (4 dose schedule)
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1155
HiB Vaccine (4 dose schedule) Administered
active
2021-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156
HiB Vaccine (3 dose schedule) Administered
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1157
HiB Vaccine (4 dose schedule) Administered
active
2024-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1158
Competing Conditions for Respiratory Conditions
active
2024-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.11.1159
Competing Conditions for Respiratory Conditions
active
2023-02
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1022
DTaP Vaccine Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1024
Hepatitis A
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1031
Measles, Mumps and Rubella (MMR) Vaccine Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1032
Mumps
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1037
Rubella
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1039
Varicella Zoster
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1040
Varicella Zoster Vaccine (VZV) Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1041
Hepatitis A Vaccine Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1042
Hepatitis B Vaccine Administered
active
2022-09
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044
Child Influenza Vaccine Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1045
Inactivated Polio Vaccine (IPV) Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1046
Pneumococcal Conjugate Vaccine Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1047
Rotavirus Vaccine (3 dose schedule) Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1048
Rotavirus Vaccine (2 dose schedule) Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1049
Genital Herpes
active
2018-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1051
Lab Tests for Sexually Transmitted Infections
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1052
Chlamydia Screening
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1053
Measles
active
2017-05
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1059
HPV Test
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1082
Advanced Illness
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1083
Hib Vaccine (3 dose schedule)
active
2019-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084
Hib Vaccine (3 dose schedule) Administered
active
2022-03
us.nlm.vsac
R4
ValueSet/2.16.840.1.113883.3.464.1003.110.12.1085
Hib Vaccine (4 dose schedule)
active
2019-03